Introduction of hAPOE3Ch into APP/PS1 mice (with and without injection of human AD-tau) resulted in decreased plaque load and AD-tau seeding and spreading, alongside increased microglial reactivity around plaques [41]. This evidence concerns the gene APP and Alzheimer disease.